GLP-1 is a hormone naturally produced in the gut that plays a critical role in regulating appetite and glucose metabolism
The FDA encourages patients and prescribers to report adverse events or quality issues linked to compounded semaglutide to the MedWatch Adverse Event Reporting Program
These limitations do not negate the temporal and dose-related signal, but they do mean the rechallenge should be read as supportive rather than confirmatory evidence, and the Naranjo score interpreted with corresponding caution
[DOI] [PMC free article] [PubMed] [Google Scholar] 27.Hatamoto Y., Tanoue Y., Yoshimura E., Matsumoto M., Hayashi T., Ogata H., Tanaka S., Tanaka H., Higaki Y
But most patients select their preference based on needle tolerance and daily routine adherence